I-Mab ADR (IMAB) is up Wednesday morning, with the stock increasing 7.81% in pre-market trading to 1.38.
IMAB's short-term technical score of 16 indicates that the stock has traded less bullishly over the last month than 84% of stocks on the market. In the Biotechnology industry, which ranks 136 out of 146 industries, IMAB ranks higher than 32% of stocks.
I-Mab ADR has fallen 34.02% over the past month, closing at $1.78 on September 6. During this period of time, the stock fell as low as $1.18 and as high as $1.82. IMAB has an average analyst recommendation of Strong Buy. The company has an average price target of $16.98.
IMAB has an Overall Score of 37. Find out what this means to you and get the rest of the rankings on IMAB!
I-Mab ADR has a Long-Term Technical rank of 6. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 94% of the market scoring higher. In the Biotechnology industry which is number 132 by this metric, IMAB ranks better than 132% of stocks.
